Orthofix Medical (OFIX) Financials: History & Chart

Orthofix Medical Inc.(OFIX)

Medical - Devices · Lewisville, TX

$9.47-0.04 (-0.37%)

Delayed quote: Oct 6, 2026, 3:00 PM EDT

About Orthofix Medical Inc.

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

Lewisville, TX

1,605 employees

www.orthofix.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Massimo Calafiore

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	833.19M	210.93M	196.71M	219.91M	205.63M	203.12M	193.65M	215.66M	196.61M
Cost of Goods Sold	253.38M	61.23M	57.16M	77.88M	57.11M	63.59M	72.03M	66.82M	61.55M
Gross Profit	579.81M	149.71M	139.55M	142.03M	148.52M	139.53M	121.62M	148.84M	135.05M
Gross Profit Margin	69.6%	71.0%	70.9%	64.6%	72.2%	68.7%	62.8%	69.0%	68.7%
Total Operating Expenses	605.22M	157.84M	153.23M	128.58M	165.57M	155.54M	170.49M	160.32M	153.95M
Research & Development	61.41M	15.94M	15.32M	15.37M	14.77M	15.93M	19.77M	18.81M	17.29M
Selling, General & Administrative	419.46M	0.00	134.91M	136.75M	147.80M	136.49M	132.98M	136.48M	130.14M
Operating Income (EBIT)	-25.41M	-8.13M	-13.69M	13.45M	-17.05M	-16.00M	-48.87M	-11.48M	-18.90M
Operating Margin	-3.1%	-3.9%	-7.0%	6.1%	-8.3%	-7.9%	-25.2%	-5.3%	-9.6%
Income Before Tax (EBT)	-60.28M	-15.00M	-20.83M	-2.19M	-22.26M	-14.22M	-52.13M	-29.71M	-26.64M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	20.78M	6.08M	5.66M	4.35M	4.68M	3.95M	4.51M	14.92M	5.21M
Other Income/Expense	-34.87M	-6.86M	-7.15M	-15.64M	-5.22M	1.78M	-3.26M	-18.23M	-7.74M
Net Income	-61.72M	-15.80M	-20.91M	-2.22M	-22.80M	-14.08M	-53.09M	-29.15M	-27.39M
Income Tax Expense	1.44M	801K	74K	30K	533K	-142K	961K	-564K	751K
Net Profit Margin	-7.4%	-7.5%	-10.6%	-1.0%	-11.1%	-6.9%	-27.4%	-13.5%	-13.9%
EBITDA	119.65M	19.55M	-193K	102.81M	-2.52M	1.99M	-13.19M	15.86M	-2.11M
EBITDA Margin	14.4%	9.3%	-0.1%	46.8%	-1.2%	1.0%	-6.8%	7.4%	-1.1%
Depreciation & Amortization	145.06M	27.68M	13.49M	89.36M	14.52M	18.00M	35.68M	27.33M	16.79M
EPS Basic	-1.54	-0.39	-0.52	-0.06	-0.57	-0.36	-1.35	-0.75	-0.71
EPS Diluted	-1.54	-0.39	-0.52	-0.06	-0.57	-0.36	-1.35	-0.75	-0.71
Weighted Average Basic Shares	40.91M	40.91M	40.45M	40.00M	39.77M	39.50M	39.20M	38.70M	38.49M
Weighted Average Diluted Shares	40.91M	40.91M	40.45M	40.00M	39.77M	39.50M	39.20M	38.70M	38.49M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	822.31M	799.49M	746.64M	460.71M	464.48M	406.56M	459.95M	453.04M
Cost of Goods Sold	270.61M	253.61M	260.37M	123.54M	114.91M	101.89M	100.61M	96.63M
Gross Profit	551.71M	545.88M	486.27M	337.17M	349.56M	304.67M	359.35M	356.41M
Gross Profit Margin	67.1%	68.3%	65.1%	73.2%	75.3%	74.9%	78.1%	78.7%
Total Operating Expenses	620.18M	630.50M	625.38M	350.44M	357.88M	310.94M	378.13M	323.25M
Research & Development	57.11M	73.64M	80.23M	49.06M	49.62M	39.06M	34.64M	33.22M
Selling, General & Administrative	456.39M	532.52M	530.39M	308.78M	290.67M	272.38M	309.28M	290.03M
Operating Income (EBIT)	-68.47M	-84.62M	-139.11M	-13.27M	-8.31M	-6.27M	-18.78M	30.09M
Operating Margin	-8.3%	-10.6%	-18.6%	-2.9%	-1.8%	-1.5%	-4.1%	6.6%
Income Before Tax (EBT)	-90.81M	-123.88M	-148.68M	-17.71M	-13.49M	-368K	-27.05M	22.89M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	17.49M	29.63M	8.63M	1.29M	1.84M	2.48M	122K	828K
Other Income/Expense	-22.34M	-39.26M	-9.57M	-4.44M	-5.18M	5.90M	-8.27M	-7.21M
Net Income	-92.19M	-126.00M	-151.40M	-19.75M	-38.38M	2.52M	-28.46M	13.81M
Income Tax Expense	1.38M	2.12M	2.72M	2.04M	24.88M	-2.88M	1.41M	9.07M
Net Profit Margin	-11.2%	-15.8%	-20.3%	-4.3%	-8.3%	0.6%	-6.2%	3.0%
EBITDA	-17.50M	-24.56M	-78.55M	18.81M	24.78M	28.01M	9.69M	48.75M
EBITDA Margin	-2.1%	-3.1%	-10.5%	4.1%	5.3%	6.9%	2.1%	10.8%
Depreciation & Amortization	50.97M	60.06M	60.56M	32.08M	33.10M	34.28M	28.48M	18.66M
EPS Basic	-2.28	-3.30	-4.12	-0.98	-1.95	0.13	-1.51	0.75
EPS Diluted	-2.28	-3.30	-4.12	-0.98	-1.95	0.13	-1.51	0.73
Weighted Average Basic Shares	39.88M	38.13M	36.73M	20.10M	19.69M	19.27M	18.90M	18.49M
Weighted Average Diluted Shares	39.88M	38.13M	36.73M	20.10M	19.69M	19.39M	18.90M	18.91M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.